Literature DB >> 825027

Mutants of Pseudomonas aeruginosa that show specific hypersensitivity to aminoglycosides.

B J Mills, B W Holloway.   

Abstract

A class of mutants in Pseudomonas aeruginosa have been found that are tolerant to aeruginocin 41 and also hypersensitive to aminoglycosides. They do not show any changes in susceptibility to a wide range of other toxic agents, including antibiotics and surfactants. This tol locus, tolA, has been mapped at 10 min from the FP2 origin and linked to carA (carbamyl phosphate synthetase) by transduction and conjugation. By selecting for revertants of the hypersensitivity phenotype, revertants to tol(+) were found, indicating that it is the tolA locus that is responsible for this specific hypersensitivity. The results indicate that a specific mechanism exists for the intrinsic resistance of P. aeruginosa to aminoglycosides.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 825027      PMCID: PMC429762          DOI: 10.1128/AAC.10.3.411

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  A genetic and biochemical study of streptomycin- and spectinomycin-resistance in Salmonella typhimurium.

Authors:  T Yamada; J Davies
Journal:  Mol Gen Genet       Date:  1971

2.  Pleiotrophy of p-fluorophenylalanine-resistant and antibiotic hypersensitive mutants of Pseudomonas aeruginosa.

Authors:  N W Dunn; B W Holloway
Journal:  Genet Res       Date:  1971-10       Impact factor: 1.588

3.  Prevalence of Pseudomonas aeruginosa strains possessing R factor in a hospital.

Authors:  Y Kawakami; F Mikoshiba; S Nagasaki; H Matsumoto; T Tazaki
Journal:  J Antibiot (Tokyo)       Date:  1972-10       Impact factor: 2.649

4.  Properties of R plasmids determining gentamicin resistance by acetylation in Pseudomonas aeruginosa.

Authors:  G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

5.  Aeruginocin tolerant mutants of Pseudomonas aeruginosa.

Authors:  B W Holloway; H Rossiter; D Burgess; J Dodge
Journal:  Genet Res       Date:  1973-12       Impact factor: 1.588

6.  The effect of complement and other cell wall reagents on tetracycline and streptomycin resistance in Pseudomonas aeruginosa.

Authors:  J T Tseng; L E Bryan
Journal:  Can J Microbiol       Date:  1974-08       Impact factor: 2.419

7.  On the mode of action of colicins: a model of regulation at the membrane level.

Authors:  J P Changeux; J Thiéry
Journal:  J Theor Biol       Date:  1967-11       Impact factor: 2.691

8.  Transferable drug resistance in Pseudomonas aeruginosa.

Authors:  L E Bryan; H M Van Den Elzen; J T Tseng
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

9.  Mutations in Escherichia coli K-12 decreasing the rate of streptomycin uptake: synergism with R-factor-mediated capacity to inactivate streptomycin.

Authors:  A K Lundbäck; K Nordström
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

10.  Phenotypic properties of R factors of Pseudomonas aeruginosa: R factors readily transferable between Pseudomonas and the Enterobacteriaceae.

Authors:  P M Chandler; V Krishnapillai
Journal:  Genet Res       Date:  1974-06       Impact factor: 1.588

View more
  20 in total

1.  Bacterial mutation affecting plasmid maintenance in Pseudomonas aeruginosa.

Authors:  B J Chang; B W Holloway
Journal:  J Bacteriol       Date:  1977-05       Impact factor: 3.490

Review 2.  Chromosomal genetics of Pseudomonas.

Authors:  B W Holloway; V Krishnapillai; A F Morgan
Journal:  Microbiol Rev       Date:  1979-03

3.  Growth-dependent alterations in production of serotype-specific and common antigen lipopolysaccharides in Pseudomonas aeruginosa PAO1.

Authors:  E J McGroarty; M Rivera
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

4.  Gentamicin interaction with Pseudomonas aeruginosa cell envelope.

Authors:  N L Martin; T J Beveridge
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

5.  Aminoglycoside-resistant mutation of Pseudomonas aeruginosa defective in cytochrome c552 and nitrate reductase.

Authors:  L E Bryan; T Nicas; B W Holloway; C Crowther
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

6.  Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.

Authors:  K Hirai; S Suzue; T Irikura; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

7.  Enhanced binding of polycationic antibiotics to lipopolysaccharide from an aminoglycoside-supersusceptible, tolA mutant strain of Pseudomonas aeruginosa.

Authors:  M Rivera; R E Hancock; J G Sawyer; A Haug; E J McGroarty
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

8.  The genetic organization of arginine biosynthesis in Pseudomonas aeruginosa.

Authors:  D Haas; B W Holloway; A Schamböck; T Leisinger
Journal:  Mol Gen Genet       Date:  1977-07-07

9.  Aminoglycoside-resistant mutants of Pseudomonas aeruginosa deficient in cytochrome d, nitrite reductase, and aerobic transport.

Authors:  L E Bryan; S Kwan
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

10.  Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria.

Authors:  L E Bryan; H M Van Den Elzen
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.